Physician profile
Aaron Horne
NPI 1326208620
$74,912.19
in general payments reported to CMS, 2019-2025
39 companies · $3,921 in 2025
The $3,921 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $9,119 · 2021: $6,208 · 2022: $8,564 · 2023: $4,979 · 2024: $5,046 · 2025: $3,921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,429 · Travel and Lodging: $3,517 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,429.26 |
| Travel and Lodging | $3,516.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21,936.98 | 2019-2025 | Lifevest |
| Cardiovascular Systems INC. | $16,425.90 | 2019-2022 | |
| Edwards Lifesciences Corporation | $10,216.18 | 2019-2025 | Evoque, Konect Resilia, Pascal |
| Pfizer INC. | $7,102.96 | 2019-2022 | |
| Medtronic, INC. | $4,831.29 | 2022-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Abbott Laboratories | $3,412.50 | 2019-2025 | Mitraclip, Diamondback Coronary, Dragonfly Opstar |
| Biotronik INC. | $2,946.25 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $2,353.95 | 2019-2022 | |
| Philips North America LLC | $1,191.09 | 2020-2025 | Igt Devices Undivided, Coronary Other, Coronary Undivided |
| Boston Scientific Corporation | $754.15 | 2019-2025 | Watchman Flx, Watchman |
| Acist Medical Systems, INC. | $573.42 | 2019-2023 | |
| Cardiva Medical, INC. | $457.23 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Savvywire, Optowire |
| Astrazeneca Pharmaceuticals Lp | $331.11 | 2019-2023 | Farxiga |
| Shockwave Medical, INC | $309.93 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Novartis Pharmaceuticals Corporation | $306.29 | 2019-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $295.53 | 2020-2022 | |
| Abiomed | $275.23 | 2019-2021 | |
| Amgen INC. | $275.23 | 2019-2025 | Repatha, Repatha |
| Chiesi USA, INC. | $164.67 | 2019-2021 | |
| Tei Biosciences INC | $114.11 | 2019 | |
| Medtronic Vascular, INC. | $96.84 | 2019-2020 | |
| Endologix LLC | $73.64 | 2024 | Torus Stent Graft System, Endocross Device |
| Bardy Diagnostics, INC. | $59.00 | 2019-2021 | |
| Livanova USA, INC. | $54.46 | 2019 | |
| Sanofi-Aventis U.S. LLC | $36.57 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $34.40 | 2019-2020 | |
| Irhythm Technologies, INC. | $30.49 | 2019 | |
| Novo Nordisk INC | $28.42 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Esperion Therapeutics, INC. | $27.67 | 2020 | |
| Merck Sharp & Dohme LLC | $25.61 | 2021 | |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Biosense Webster, INC. | $22.72 | 2019 | |
| Janssen Pharmaceuticals, INC | $22.22 | 2020 | |
| Arbor Pharmaceuticals, INC. | $21.74 | 2020 | |
| Alnylam Pharmaceuticals INC. | $21.64 | 2019 | |
| Surmodics, INC. | $20.74 | 2022 | |
| Cardinal Health 200 LLC | $14.22 | 2019 | |
| Baxter Healthcare | $13.37 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Medicure Pharma INC. | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Horne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.